Skip to main content

Find Clinical Trials

Home
Conditions
Liver Neoplasms

Clinical trial condition

Liver Neoplasms

Explore clinical trials studying Liver Neoplasms. Study availability and eligibility vary by location and protocol.

1,743 public trials 463 recruiting studies

Refine in advanced search Browse all conditions

Liver Neoplasms trial results

Recruiting

Immunophenotype of PBMC to Early Predict Response to Immunotherapy in Hepatocellular Carcinoma

NCT06777628

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: IRCCS-Azienda Ospedaliero-Universitaria di Bologna Bologna, Laura Gramantieri, Italy

View Trial Details

Recruiting

Can Hepatic-splenic Elastography Predict the Risk of Hepatocellular Recurrence After Radiofrequency Ablation?

NCT06777017

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: IRCCS Azienda Ospedaliero - Universitaria di Bologna Bologna, Italy

View Trial Details

Recruiting

Intra Artherial Therapies in Treatment of Primary Liver Diseases: an Observational Study

NCT06774690

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy

View Trial Details

Recruiting

TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT

NCT06622031

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
Locations: Chinese PLA General hospital Beijing, None Selected, China

View Trial Details

Recruiting

Comparison of the Incidence of Delirium Caused by Different Anesthetic Agents in Patients Undergoing Liver Transplantation

NCT06767579

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
Locations: Department of Anesthesiology and Pain Medicine Yonsei University College of Medicine Seoul, South Korea

View Trial Details

Recruiting

A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers

NCT06422403

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +28 more
Locations: Department of Hematology-Oncology, National University Hospita Singapore

View Trial Details

Recruiting

Stereotactic Radiosurgery Versus Radiofrequency Ablation for Primary Liver Cancer

NCT06766643

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Department of Hepatobiliary Oncology and Radiation Oncology,Tianjin Medical University Cancer Institute & Hospital,Key Laboratory of Cancer Prevention and Therapy,National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer Tianjin, China

View Trial Details

Recruiting

Tislelizumab or Tislelizumab Combined With Lenvatinib Neo-adjuvant Treatment for Resectable RHCC

NCT04615143

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: The First Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Recruiting

Clinical Study on the Effectiveness and Safety of Lenvatinib As Adjuvant Treatment for Patients with High-risk Recurrence of Hepatocellular Carcinoma After Surgery

NCT06762782

Conditions: Adenocarcinoma, Adjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or Ablation, Carcinoma, +10 more
Locations: The First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Recruiting

The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in Intermediate-stage HepatoCellular Carcinoma

NCT04803994

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: LKH - Univ. Klinikum Graz Graz, Austria

Medzinische Universität Innsbruck Innsbruck, Austria

Klinikum Klagenfurt am Wörthersee Klagenfurt, Austria

Ordensklinikum Linz Linz, Austria

View all 72 locations

View Trial Details